Positive for Respiratory Syncytial Virus? Join Our Research Study

Ascada Research is inviting individuals positive for Respiratory Syncytial Virus who are also at high risk (as defined below) to participate in a clinical study.
This study is evaluating a potential RSV treatment option and participants in the study will be randomly selected either to receive the investigational treatment or a placebo.
Study volunteers will be expected to attend approximately 6 in-office visits at our Fullerton location over the span of 33 days.
All study-related treatments and procedures are provided at no-cost to participants.
Participation is always voluntary, and individuals may discontinue participation at any point during the study.
Qualified Participants Include: • Adults 18 years or older • Adults who are at high risk of complications from RSV [adults who either 1) have Congestive Heart Failure, 2) have Asthma, or 3) have COPD or 4) are 65 years or older] • Adults who started experiencing RSV symptoms no more than 3 days ago (such as cough, fever, runny nose, headache, fatigue, etc.
) • Adults who are RSV positive (RSV testing provided at no-cost for pre-qualified individuals) ✅ CLICK HERE TO SIGN UP ✅ Ascada Research Open M-F 8:00am-4:30pm Fullerton: (657)-214-3679 www.
AscadaResearch.
org